The efficacy and safety of adding bevacizumab in neoadjuvant therapy for locally advanced rectal cancer patients: A systematic review and meta-analysis

BACKGROUND: Patients with locally advanced rectal cancer (LARC) are more likely to suffer local recurrence and distant metastases, contributing to worse prognoses. Considering the provided dramatic reduction of local recurrences, neoadjuvant CRT (nCRT) followed by curative resection with total mesor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yue, Guo, Zhexu, Wu, Zhonghua, Shi, Jinxin, Zhou, Cen, Sun, Jie, Hidasa, Iko, Lu, Xuefei, Lu, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704460/
https://www.ncbi.nlm.nih.gov/pubmed/33248411
http://dx.doi.org/10.1016/j.tranon.2020.100964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704460/
https://www.ncbi.nlm.nih.gov/pubmed/33248411
http://dx.doi.org/10.1016/j.tranon.2020.100964

Ejemplares similares